Select Publications

Journal articles

Lafferty L; Schroeder S; Marshall AD; Drysdale K; Higgs P; Stoové M; Baldry E; Dietze P; Treloar C, 2023, 'Trust and service engagement among people who inject drugs after release from prison', International Journal of Drug Policy, 111, http://dx.doi.org/10.1016/j.drugpo.2022.103925

Broom A; Peterie M; Kenny K; Broom J; Kelly-Hanku A; Lafferty L; Treloar C; Applegate T, 2023, 'Vulnerability and antimicrobial resistance', Critical Public Health, 33, pp. 308 - 317, http://dx.doi.org/10.1080/09581596.2022.2123733

Bryant J; Bolt R; Martin K; Beadman M; Doyle M; Treloar C; Bell S; Murphy D; Newman C; Browne A; Aggleton P; Beetson K; Brooks M; Wilms J; Leece B; Stanbury L; Botfield J; Davis B; Graham S, 2023, 'Yarning as a method for building sexual wellbeing among urban Aboriginal young people in Australia', Culture, Health and Sexuality, http://dx.doi.org/10.1080/13691058.2023.2258948

Marshall AD; Schroeder SE; Lafferty L; Drysdale K; Baldry E; Stoové M; Dietze P; Higgs P; Treloar C, 2023, 'Perceived access to opioid agonist treatment in prison among people with a history of injection drug use: A qualitative study.', J Subst Use Addict Treat, 150, pp. 209066, http://dx.doi.org/10.1016/j.josat.2023.209066

Treloar C; Cama E; Lancaster K; Brener L; Broady TR; Cogle A; O’Donnell D, 2022, 'A universal precautions approach to reducing stigma in health care: getting beyond HIV-specific stigma', Harm Reduction Journal, 19, http://dx.doi.org/10.1186/s12954-022-00658-w

Valerio H; Conway A; Alavi M; Treloar C; Silk D; Murray C; Henderson C; Amin J; Read P; Degenhardt L; Christmass M; Montebello M; Dore GJ; Grebely J, 2022, 'Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy: The ETHOS Engage study', International Journal of Drug Policy, 110, http://dx.doi.org/10.1016/j.drugpo.2022.103876

Silano JA; Treloar C; Leadbeatter K; Davidson S; Doidge J, 2022, 'Peer-facilitated treatment access for hepatitis C: the Live Hep C Free project', Harm Reduction Journal, 19, http://dx.doi.org/10.1186/s12954-022-00619-3

Silano JA; Treloar C; Wright T; Brown T; McGrath C; Snoyman P, 2022, 'Commentary on the harm reduction reference group of justice health and forensic mental health network and corrective services NSW, Australia', International Journal of Prisoner Health, 18, pp. 394 - 406, http://dx.doi.org/10.1108/IJPH-06-2021-0050

Wallace J; Richmond J; Howell J; Hajarizadeh B; Power J; Treloar C; Revill PA; Cowie B; Wang S; Stoové M; Pedrana A; Hellard M, 2022, 'Exploring the Public Health and Social Implications of Future Curative Hepatitis B Interventions', Viruses, 14, http://dx.doi.org/10.3390/v14112542

Carson JM; Dore GJ; Lloyd AR; Grebely J; Byrne M; Cunningham E; Amin J; Vickerman P; Martin NK; Treloar C; Martinello M; Matthews GV; Hajarizadeh B, 2022, 'Hepatitis C Virus Reinfection Following Direct-Acting Antiviral Treatment in the Prison Setting: The SToP-C Study', Clinical Infectious Diseases, 75, pp. 1809 - 1819, http://dx.doi.org/10.1093/cid/ciac246

Zhang Y; Guy R; Camara H; Applegate TL; Wiseman V; Treloar C; Lafferty L, 2022, 'Barriers and facilitators to HIV and syphilis rapid diagnostic testing in antenatal care settings in low-income and middle-income countries: A systematic review', BMJ Global Health, 7, http://dx.doi.org/10.1136/bmjgh-2022-009408

Jin D; Brener L; Treloar C, 2022, 'Hepatitis B-related stigma among Chinese immigrants living with hepatitis B virus in Australia: A qualitative study', Health and Social Care in the Community, 30, pp. e5602 - e5611, http://dx.doi.org/10.1111/hsc.13986

Marshall AD; Martinello M; Treloar C; Matthews GV, 2022, 'Perceptions of hepatitis C treatment and reinfection risk among HIV-positive men who have sex with men and engage in high risk behaviours for hepatitis C transmission: The CEASE qualitative study', International Journal of Drug Policy, 109, http://dx.doi.org/10.1016/j.drugpo.2022.103828

Jin D; Brener L; Treloar C, 2022, 'Trust in healthcare providers among Chinese immigrants living with hepatitis B virus in Australia: A qualitative study', Journal of Viral Hepatitis, 29, pp. 968 - 975, http://dx.doi.org/10.1111/jvh.13736

Drysdale K; Rance J; Cama E; Treloar C; Mao L, 2022, 'What is known about the care and support provided for an ageing population with lived experience of chronic viral hepatitis as they near end-of-life: A scoping review', Health and Social Care in the Community, 30, pp. e3775 - e3788, http://dx.doi.org/10.1111/hsc.14066

Treloar C; Lancaster K; Gendera S; Rhodes T; Shahbazi J; Byrne M; Degenhardt L; Farrell M, 2022, 'Can a new formulation of opiate agonist treatment alter stigma?: Place, time and things in the experience of extended-release buprenorphine depot', International Journal of Drug Policy, 107, http://dx.doi.org/10.1016/j.drugpo.2022.103788

Fraser S; Moore D; Farrugia A; Fomiatti R; Edwards M; Birbilis E; Treloar C, 2022, 'Exhausted practical sovereignty and lateral agency: Non-uptake of treatment for hepatitis C in the antiviral era', International Journal of Drug Policy, 107, http://dx.doi.org/10.1016/j.drugpo.2022.103771

Lafferty L; Rance J; Byrne M; Milat A; Dore GJ; Grebely J; Lloyd AR; Treloar C, 2022, '“You need a designated officer” – Recommendations from correctional and justice health personnel for scaling up hepatitis C treatment-as-prevention in the prison setting', International Journal of Drug Policy, 106, http://dx.doi.org/10.1016/j.drugpo.2022.103746

Wheeler A; Valerio H; Cunningham EB; Martinello M; Barocas JA; Colledge-Frisby S; Treloar C; Amin J; Henderson C; Read P; Matthews GV; Dunlop AJ; Gorton C; Hayllar J; Alavi M; Murray C; Marks P; Silk D; Degenhardt L; Dore GJ; Grebely J, 2022, 'Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage Study', Drug and Alcohol Dependence, 237, http://dx.doi.org/10.1016/j.drugalcdep.2022.109543

Conway A; Valerio H; Alavi M; Silk D; Treloar C; Hajarizadeh B; Marshall AD; Martinello M; Milat A; Dunlop A; Murray C; Prain B; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Hayllar J; Reid D; Gorton C; Lam T; Christmass M; Wade A; Montebello M; Dore GJ; Grebely J, 2022, 'A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study', Viruses, 14, http://dx.doi.org/10.3390/v14071555

Brener L; Caruana T; Broady T; Cama E; Ezard N; Madden A; Treloar C, 2022, 'Addressing injecting related risks among people who inject both opioids and stimulants: Findings from an Australian survey of people who inject drugs', Addictive Behaviors Reports, 15, http://dx.doi.org/10.1016/j.abrep.2021.100398

Gendera S; Treloar C; Reilly R; Conigrave KM; Butt J; Roe Y; Ward J, 2022, '‘Even though you hate everything that’s going on, you know they are safer at home’: The role of Aboriginal and Torres Strait Islander families in methamphetamine use harm reduction and their own support needs', Drug and Alcohol Review, pp. 1 - 12, http://dx.doi.org/10.1111/dar.13481

Larney S; Madden A; Marshall AD; Martin NK; Treloar C, 2022, 'A gender lens is needed in hepatitis C elimination research', International Journal of Drug Policy, 103, http://dx.doi.org/10.1016/j.drugpo.2022.103654

Jin D; Brener L; Treloar C, 2022, 'Knowledge and beliefs about hepatitis B virus infection and associated factors among Chinese migrants in Australia: The result of a quantitative study', Health and Social Care in the Community, 30, pp. 918 - 925, http://dx.doi.org/10.1111/hsc.13239

Marshall AD; Rance J; Grebely J; Treloar C, 2022, '‘Not just one box that you tick off’ – Deconstructing the hepatitis C care cascade in the interferon-free direct acting antiviral era from the client perspective', International Journal of Drug Policy, 102, http://dx.doi.org/10.1016/j.drugpo.2022.103610

Farrugia A; Fomiatti R; Fraser S; Moore D; Edwards M; Birbilis E; Treloar C, 2022, 'Hepatitis C cure as a ‘gathering’: Attending to the social and material relations of hepatitis C treatment', Sociology of Health and Illness, 44, pp. 830 - 847, http://dx.doi.org/10.1111/1467-9566.13467

Schroeder SE; Drysdale K; Lafferty L; Baldry E; Marshall AD; Higgs P; Dietze P; Stoove M; Treloar C, 2022, '"It's a revolving door": Ego-depletion among prisoners with injecting drug use histories as a barrier to post-release success', International Journal of Drug Policy, 101, http://dx.doi.org/10.1016/j.drugpo.2021.103571

Lafferty L; Cochrane A; Sheehan Y; Treloar C; Grebely J; Lloyd AR, 2022, '“That was quick, simple, and easy”: Patient perceptions of acceptability of point-of-care hepatitis C RNA testing at a reception prison', International Journal of Drug Policy, 99, http://dx.doi.org/10.1016/j.drugpo.2021.103456

Brener L; Cama E; Broady T; Hopwood M; Treloar C, 2022, 'Comparing Australian health worker and student attitudes and concerns about providing care to people living with hepatitis B', Health Promotion Journal of Australia, 33, pp. 282 - 288, http://dx.doi.org/10.1002/hpja.475

Jin D; Treloar C; Brener L, 2022, 'Hepatitis B virus related stigma among Chinese living in mainland China: a scoping review', Psychology, Health and Medicine, 27, pp. 1760 - 1773, http://dx.doi.org/10.1080/13548506.2021.1944651

Farrugia A; Treloar C; Fraser S, 2022, 'Overdoselifesavers.org: a mixed-method evaluation of a public information website on experiences of overdose and using take-home naloxone to save lives', Drugs: Education, Prevention and Policy, 29, pp. 43 - 53, http://dx.doi.org/10.1080/09687637.2020.1858758

Fomiatti R; Farrugia A; Fraser S; Moore D; Edwards M; Treloar C, 2022, 'Post-crisis imaginaries in the time of direct-acting antiviral hepatitis C treatment', Time and Society, http://dx.doi.org/10.1177/0961463X221128736

Karlsen TH; Sheron N; Zelber-Sagi S; Carrieri P; Dusheiko G; Bugianesi E; Pryke R; Hutchinson SJ; Sangro B; Martin NK; Cecchini M; Dirac MA; Belloni A; Serra-Burriel M; Ponsioen CY; Sheena B; Lerouge A; Devaux M; Scott N; Hellard M; Verkade HJ; Sturm E; Marchesini G; Yki-Järvinen H; Byrne CD; Targher G; Tur-Sinai A; Barrett D; Ninburg M; Reic T; Taylor A; Rhodes T; Treloar C; Petersen C; Schramm C; Flisiak R; Simonova MY; Pares A; Johnson P; Cucchetti A; Graupera I; Lionis C; Pose E; Fabrellas N; Ma AT; Mendive JM; Mazzaferro V; Rutter H; Cortez-Pinto H; Kelly D; Burton R; Lazarus JV; Ginès P; Buti M; Newsome PN; Burra P; Manns MP, 2022, 'The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality', The Lancet, 399, pp. 61 - 116, http://dx.doi.org/10.1016/S0140-6736(21)01701-3

Valerio H; Alavi M; Conway A; Silk D; Treloar C; Martinello M; Milat A; Dunlop A; Murray C; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Stevens A; Prain B; Hayllar J; Reid D; Montebello M; Wade A; Christmass M; Cock V; Dore GJ; Grebely J; ETHOS Engage Study Group , 2022, 'Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study.', Int J Drug Policy, 105, pp. 103706, http://dx.doi.org/10.1016/j.drugpo.2022.103706

Rance J; Lafferty L; Treloar C; Loveday S; Dore G; Lloyd A; Grebely J; Butler T; Martin N; Chambers G; Byrne M; Donnelly R; McGrath C; Bowman J; Trevethan L; Grant L; Murrell T; Bath N; Harrod M; Churchill A; Pinnock K; Cairnduff S, 2021, 'Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian ‘surveillance and treatment of prisoners with hepatitis C’ project (SToP-C)', Harm Reduction Journal, 18, http://dx.doi.org/10.1186/s12954-021-00494-4

Djordjevic F; Ryan K; Gunn J; Brener L; O’Keefe D; Draper B; Schroeder S; Gold J; Treloar C; Broady T; Dietze P; Hellard M; Pedrana A, 2021, 'Health service utilization and experiences of stigma amongst people who inject drugs in Melbourne, Australia', Journal of Viral Hepatitis, 28, pp. 1738 - 1743, http://dx.doi.org/10.1111/jvh.13612

Lafferty L; Rance J; Dore GJ; Grebely J; Lloyd AR; Treloar C, 2021, 'Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel', International Journal of Drug Policy, 98, http://dx.doi.org/10.1016/j.drugpo.2021.103379

Walker S; Wallace J; Latham N; Saich F; Pedrana A; Hellard M; Treloar C; Marukutira T; Higgs P; Doyle J; Stoové M, 2021, '“It's time!”: A qualitative exploration of the acceptability of hepatitis C notification systems to help eliminate hepatitis C', International Journal of Drug Policy, 97, http://dx.doi.org/10.1016/j.drugpo.2021.103280

Cama E; Brener L; Broady T; Hopwood M; Treloar C, 2021, 'Australian health and medical workers’ concerns around providing care to people living with hepatitis B', Health and Social Care in the Community, 29, pp. e431 - e439, http://dx.doi.org/10.1111/hsc.13368

Brener L; Broady T; Cama E; Hopwood M; Byrne J; Treloar C, 2021, 'Positive effects of community attachment on internalised stigma and wellbeing among people who inject drugs', International Journal of Drug Policy, 97, http://dx.doi.org/10.1016/j.drugpo.2021.103323

Rance J; Lafferty L; Treloar C; Loveday S; Dore G; Lloyd A; Grebely J; Butler T; Martin N; Chambers G; Byrne M; Donnelly R; McGrath C; Bowman J; Trevethan L; Grant L; Murrell T; Bath N; Harrod M; Churchill A; Pinnock K; Cairnduff S, 2021, 'Expert stakeholder perspectives on the acceptability of treatment-as-prevention in prison: a qualitative substudy of the ‘Surveillance and Treatment of Prisoners with Hepatitis C’ project (SToP-C)', Addiction, 116, pp. 2761 - 2769, http://dx.doi.org/10.1111/add.15477

Kelly PJ; Beck AK; Deane FP; Larance B; Baker AL; Hides L; Manning V; Shakeshaft A; Neale J; Kelly JF; Oldmeadow C; Searles A; Palazzi K; Lawson K; Treloar C; Gray RM; Argent A; McGlaughlin R, 2021, 'Feasibility of a mobile health app for routine outcome monitoring and feedback in SMART recovery mutual support groups: Stage 1 mixed methods pilot study', Journal of Medical Internet Research, 23, http://dx.doi.org/10.2196/25217

Conway A; Valerio H; Peacock A; Degenhardt L; Hayllar J; Harrod ME; Henderson C; Read P; Gilliver R; Christmass M; Dunlop A; Montebello M; Whitton G; Reid D; Lam T; Alavi M; Silk D; Marshall AD; Treloar C; Dore GJ; Grebely J, 2021, 'Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study', International Journal of Drug Policy, 96, http://dx.doi.org/10.1016/j.drugpo.2021.103421

Broady TR; Brener L; Vuong T; Cama E; Treloar C, 2021, 'Online interventions to reduce stigma towards population groups affected by blood borne viruses in Australia', International Journal of Drug Policy, 96, http://dx.doi.org/10.1016/j.drugpo.2021.103292

Grebely J; Collins AB; Artenie AA; Sutherland R; Meyer JP; Barocas JA; Falade-Nwulia O; Cepeda JA; Cunningham EB; Hajarizadeh B; Lafferty L; Lazarus JV; Bonn M; Marshall AD; Treloar C, 2021, 'Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs', International Journal of Drug Policy, 96, http://dx.doi.org/10.1016/j.drugpo.2021.103469

Treloar C; Schroeder S; Lafferty L; Marshall A; Drysdale K; Higgs P; Baldry E; Stoove M; Dietze P, 2021, 'Structural competency in the post-prison period for people who inject drugs: A qualitative case study', International Journal of Drug Policy, 95, http://dx.doi.org/10.1016/j.drugpo.2021.103261

Treloar C; Hopwood M; Drysdale K; Lea T; Holt M; Dowsett GW; Aggleton P; Bryant J, 2021, 'Stigma as understood by key informants: A social ecological approach to gay and bisexual men's use of crystal methamphetamine for sex', International Journal of Drug Policy, 94, http://dx.doi.org/10.1016/j.drugpo.2021.103229

Bryant J; Bolt R; Botfield JR; Martin K; Doyle M; Murphy D; Graham S; Newman CE; Bell S; Treloar C; Browne AJ; Aggleton P, 2021, 'Beyond deficit: ‘strengths-based approaches’ in Indigenous health research', Sociology of Health and Illness, 43, pp. 1405 - 1421, http://dx.doi.org/10.1111/1467-9566.13311

Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; McManus H; Butler T; Cunningham EB; Vickerman P; Martin NK; McHutchison JG; Brainard DM; Treloar C; Chambers GM; Grant L; Mcgrath C; Lloyd AR; Dore GJ; Loveday S; Tamaddoni M; Obeid S; Estivill Mercade G; Martinez M; Donnelly R; Bowman J; Trevethan L; Lagios K; Murrell T; Bath N; Tawil V; Stevens A; Topp L; Churchill A; Pinnock K; Martin N; Drew S; Harrod M; Smith A; Williams R; Cooper B; Somes K; Burns C; Kaur A; Lobo C; Conroy K; McCredie L; Café C; Anlezark J; Rawlinson W; Yeang M; Wynn M; Willenborg C, 2021, 'Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study', The Lancet Gastroenterology and Hepatology, 6, pp. 533 - 546, http://dx.doi.org/10.1016/S2468-1253(21)00077-7

Valerio H; Alavi M; Silk D; Treloar C; Martinello M; Milat A; Dunlop A; Holden J; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Hayllar J; Reid D; Gorton C; Lam T; Dore G; Grebely J, 2021, 'Progress towards Elimination of Hepatitis C Infection among People Who Inject Drugs in Australia: The ETHOS Engage Study', Clinical Infectious Diseases, 73, pp. E69 - E78, http://dx.doi.org/10.1093/cid/ciaa571


Back to profile page